Skip to main content
. Author manuscript; available in PMC: 2014 Sep 19.
Published in final edited form as: Mol Imaging Biol. 2013 Oct 30;16(3):431–440. doi: 10.1007/s11307-013-0699-7

Table 2. Lesion level and patient level summaries of FES PET and FDG PET measures.

N N (%) or median (min–max)
Lesion level
Tumor site 124
 Breast 5 (4 %)
 Soft tissue/nodes 52 (42 %)
 Spine 32 (26 %)
Other bone 35 (28 %)
FES PET SUVmean (dynamic FOV) 56 2.2 (0.4,7.7)
FES PET SUVmean 124 2.0 (0.0,8.3)
FDG PET SUVmax 124 4.6 (1.3,17.3)
Ratio (FES PET SUVmax/FDG PET SUVmax) 124 0.7 (0.1,3.6)
Patient level
Any FES qualitatively negative sites 19
 No 13 (68 %)
 Yes 6 (32 %)
Average FES PET SUVmean (dynamic FOV) 19 2.0 (0.6, 5.9)
Geometric mean of SUVmean (three highest FDGmax-sweep) 19 2.2 (0.4, 6.5)
Average of sqrt(FES/FDG ratio) (three highest FDGmax-sweep) 19 0.9 (0.3, 1.5)